NEW YORK (GenomeWeb) – Trovagene said after the close of the market on Thursday that its fourth quarter revenues increased 19 percent year over year. 

The San Diego-based developer of cell-free molecular diagnostics said it posted $56,000 in revenues for the three months ended Dec. 31, 2014, up from $47,000 in the year-ago quarter. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.